Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma (Q36002345)

11 August 2017

title

Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma (English)

1 reference

cost-effectiveness analysis

11 August 2017

0 references

1 reference

5

Bengt Glimelius

1 reference

11 August 2017

Jonas Lundkvist

1

1 reference

11 August 2017

Mattias Ekman

series ordinal

2

1 reference

11 August 2017

Suzanne Rehn Ericsson

series ordinal

3

1 reference

11 August 2017

Bengt Jönsson

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

11 August 2017

volume

103

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

793-801

1 reference

Potential gains using high-energy protons for therapy of malignant tumours

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Medulloblastoma: signalling a change in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Postirradiation sensorineural hearing loss: a common but ignored late radiation complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Therapy-associated solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Updated estimates of earnings benefits from reduced exposure of children to environmental lead.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Long-term risk of osteoporotic fracture in Malmö.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Changes in quality of life and the cost-utility associated with cochlear implantation in patients with large vestibular aqueduct syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

21 January 2018

Costs of Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

Proton beams to replace photon beams in radical dose treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Societal benefits of reducing lead exposure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Fracture risk following an osteoporotic fracture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Mortality after osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Cost effectiveness of screening for subclinical hypothyroidism in the elderly. A decision-analytical model.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Decreased psychological well-being in adult patients with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

The relative costs of proton and X-ray radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

The burden of illness of hypopituitary adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20844

7 January 2021

Identifiers

DOI

10.1002/CNCR.20844

1 reference

11 August 2017

1 reference